Vas deferens--a model used to establish sympathetic cotransmission.
about
Structure activity relationship of synaptic and junctional neurotransmissionMolecular and functional properties of P2X receptors--recent progress and persisting challengesPurinergic signalling in the reproductive system in health and diseaseThe purinergic neurotransmitter revisited: a single substance or multiple players?Differential activation of an identified motor neuron and neuromodulation provide Aplysia's retractor muscle an additional functionThe residual nonadrenergic contractile response to nerve stimulation of the mouse prostate is mediated by acetylcholine but not ATP in a comparison with the mouse vas deferens.Nucleoside triphosphate diphosphohydrolase-1 ectonucleotidase is required for normal vas deferens contraction and male fertility through maintaining P2X1 receptor function.Neuronal and non-neuronal modulation of sympathetic neurovascular transmission.Purinergic signalling during development and ageing.Tyramine Reveals Failing α2-Adrenoceptor Control of Catecholamine Release and Total Peripheral Vascular Resistance in Hypertensive Rats.Physiological and pharmacological aspects of the vas deferens-an updateRegulation of nerve-evoked contractions of rabbit vas deferens by acetylcholine.Big conductance calcium-activated potassium channel openers control spasticity without sedation.Effect of Boerhaavia diffusa in experimental prostatic hyperplasia in rats.Discovery of purinergic signalling, the initial resistance and current explosion of interest.Relationship between central behavioral effects and peripheral sympathetic neurotransmission functionality during acute cocaine withdrawal syndrome in adult rats.
P2860
Q24614229-99911AE5-1917-492D-BC5F-C0028F7042DFQ24617046-5092F8AB-0957-4335-9217-24ECDBE9F266Q26820842-50697CC4-592E-44BE-BBE5-E94BA2015F40Q26824817-C2ADFF94-8384-442D-A417-5BE20E9F5E21Q34006636-91A49303-F164-4517-AB60-F6F3CB3567D5Q34257555-5886A349-4AAA-4CBE-835E-DE5BB6F1E80FQ34317478-AF2B852E-EA1D-4800-81BE-628C5A65209AQ35116071-47BAC2DA-93C4-4430-82C2-5888F5CBDC9DQ35930763-AC53660E-7DC3-411D-A29A-A6C68683787BQ36644682-C4BBE4EA-BEF4-49BB-8138-D5082865F535Q37111681-A9B08D30-95C5-4FF4-94C4-0F962ABB96DAQ40550773-A2637563-21E3-41AC-BA80-836BB0B25385Q41098063-0CA08C46-3A5E-4D39-A24D-FE6D5F706A6AQ41483420-F4A7C821-A372-4DF8-87EE-073C98A703B8Q41954765-2CD8DC51-861C-4A9A-85DE-A30BCA49EF6CQ47626317-07B8A6FE-11CA-4F9E-B376-36D1810F30E4
P2860
Vas deferens--a model used to establish sympathetic cotransmission.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Vas deferens--a model used to establish sympathetic cotransmission.
@ast
Vas deferens--a model used to establish sympathetic cotransmission.
@en
Vas deferens--a model used to establish sympathetic cotransmission.
@nl
type
label
Vas deferens--a model used to establish sympathetic cotransmission.
@ast
Vas deferens--a model used to establish sympathetic cotransmission.
@en
Vas deferens--a model used to establish sympathetic cotransmission.
@nl
prefLabel
Vas deferens--a model used to establish sympathetic cotransmission.
@ast
Vas deferens--a model used to establish sympathetic cotransmission.
@en
Vas deferens--a model used to establish sympathetic cotransmission.
@nl
P1476
Vas deferens--a model used to establish sympathetic cotransmission
@en
P2093
Geoffrey Burnstock
P304
P356
10.1016/J.TIPS.2009.12.002
P577
2010-01-13T00:00:00Z